Please Note: You are viewing the non-styled version of SITE NAME. Either your browser does not support Cascading Style Sheets (CSS) or it is disabled. We suggest upgrading your browser to the latest version of your favorite Internet browser.
On October 16, 2013, the State Board of Emergency Medical, Fire and Transportation Services (EMFTS Board) approved the expansion of the Ohio EMS scope of practice to allow emergency medical responders and emergency medical technicians to administer intranasal naloxone, upon completion of training and the approval of the medical director, to a person suspected of suffering from an opioid overdose.
On April 3, 2014, the FDA approved EVZIO®, a hand-held auto-injector produced by Kaléo pharmaceutical company that rapidly delivers a single dose of naloxone, as a prescription treatment for a person with a known or suspected opioid overdose. On April 16, 2014, the EMFTS Board approved the expansion of the Ohio EMS scope of practice to allow emergency medical responders and emergency medical technicians to administer naloxone via auto-injector, upon completion of training and the approval of the medical director, to a person suspected of suffering from an opioid overdose.
EVZIO® is scheduled to be available to licensed drug prescribers on July 1, 2014. In preparation for this release, the EMFTS Board approved an updated naloxone administration training module reflecting the expanded Ohio EMS scope of practice on June 18, 2014. The PowerPoint presentation on naloxone administration by auto-injector and the intranasal route below is designed to assist local EMS and fire agencies and local medical directors in meeting training requirements before implementing the Ohio EMFTS Board’s updated scope of practice for Ohio certified emergency medical responders (EMRs) and emergency medical technicians (EMTs) for the field administration of intranasal naloxone and naloxone auto-injectors.
This naloxone training program is not mandatory for all Ohio certified EMRs and EMTs, but local training, written protocols, and medical director approval are required before the local medical director allows the Ohio certified EMRs and EMTs to perform the intranasal naloxone procedures in the field.
The Ohio Department of Public Safety, Division of EMS is working with our training section to have this training posted on the Ohio Department of Public Safety’s Public Safety Training Campus (PSTC) in the near future as an Ohio EMS Online CE Training opportunity.
Ohio EMFTS Board accredited and Ohio EMFTS Board approved training institutions can develop and provide this training from the PowerPoint presentations into an EMS continuing education opportunity following Ohio Administrative Code (OAC) 4765-7-09.